Peters, Steffie M. B.
Hofferber, Regina
Privé, Bastiaan M.
de Bakker, Maarten
Gotthardt, Martin
Janssen, Marcel
de Lange, Frank
Muselaers, Constantijn H. J.
Mehra, Niven
Witjes, J. Alfred
Costa, Pedro F.
Nagarajah, James
Konijnenberg, Mark W.
Jentzen, Walter
Funding for this research was provided by:
Siemens Healthineers
Radboud Oncology Foundation
Dutch Prostate Cancer Foundation
Article History
Received: 7 June 2021
Accepted: 23 August 2021
First Online: 8 October 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Medical Review Ethics Committee Region Arnhem-Nijmegen and was registered on clinicaltrials.gov (NCT03828838).
: All subjects provided written informed consent before study entry.
: Patients signed informed consent regarding publishing their data.
: W. Jentzen received research funding from Siemens Healthineers. Partial financial support was received from the Radboud Oncology Foundation and the Dutch Prostate Cancer Foundation.